14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for SRNE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.307 .
R2 0.307 .
R1 0.307 .
Current price: 0.307
Support S1 0.307 .
S2 0.307 .
S3 0.307 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0.310 0.88 %
Current price 0.307
Support S1 0.258 -16.08%
S2 0.257 -16.30%
S3 0 .

SRNE Predictions History

3 years ago
JS predicted that SRNE for 2021-02-17 is going $13.83 (-1.07%)

3 years ago
vfoltan predicted that SRNE for 2021-02-17 is going

Rank:

3 years ago
JS predicted that SRNE for 2021-02-08 is going $13.57 (-17.81%)

3 years ago
JS predicted that SRNE for 2021-01-20 is going $9.00 (-10.27%)

3 years ago
Baltzera predicted that SRNE for 2021-01-20 is going

3 years ago
128030 predicted that SRNE for 2021-01-20 is going

Rank:

3 years ago
ניסים כהן predicted that SRNE for 2021-01-15 is going $7.99 (-15.89%)

Rank:

3 years ago
JS predicted that SRNE for 2020-12-15 is going $7.12 (1.28%)

3 years ago
CORealtor predicted that SRNE for 2020-12-15 is going $7.40 (5.26%)

3 years ago
JS predicted that SRNE for 2020-12-08 is going $7.43 (-5.95%)

Click to get the best stock tips daily for free!

About Sorrento Therapeutics

Sorrento Therapeutics Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric... SRNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT